Topic: breast cancer metastasis
Camel-IDS will run a phase 1b/2 trial of its lead radiopharmaceutical in HER2-positive breast cancer that has spread to the brain.
Recent biotech developments include improved viral delivery vehicles for gene therapy and compounds that cripple resistant bacteria.
New biotech discoveries include CRISPR-induced conception and a biomarker for predicting breast cancer recurrences.
Modifying tumor cells instead of immune cells from patients is showing promising results in animal models of breast and brain cancer.
Removing a protein called Munc13-4 could stop breast cancer cells from releasing exosomes, which carry proteins and RNAs that promote tumor metastasis.
Biotech developments over the past week include a new idea for halting metastasis in breast cancer and a new method for reversing atherosclerosis.
Researchers have enrolled 2,000 people with metastatic breast cancer in 7 months using a social media-enabled, direct-to-patient model of recruiting.